Join
Live feed
·
INSIDERFilingvia Quantisnow
Repare Therapeutics Inc. logo

EVP, CHIEF SCIENTIFIC OFFICER Zinda Michael was granted 14,000 shares, increasing direct ownership by 19% to 85,908 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RPTX· Repare Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPTX (Repare Therapeutics Inc.) and more on Quantisnow.